N/A
N=131
Dry Needling in Patients With Chronic Neck Pain
Neck Pain
Bottom Line
View on ClinicalTrials.gov: NCT02435966 ↗Enrolled (actual)
131
Serious AEs
0.0%
Results posted
Sep 2015
Primary outcome: Primary: Change in Pain Scores on the Visual Analog Scale (VAS: 0-10) After 30 Days — 1.77; 3.34; 8.83 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dry needling (Device); Sham Dry needling (Device); Manual therapy (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- European University of Madrid
- Primary completion
- Jun 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Scores on the Visual Analog Scale (VAS: 0-10) After 30 Days |
1.77; 3.34; 8.83 | — |
| SECONDARY Change in the Pressure Pain Threshold Measured by Algometer |
— | — |
| SECONDARY Change in the Cervical Range of Motion Measured by Goniometer |
— | — |
| SECONDARY Change in the Neck Disability Index Questionnaire |
— | — |
Summary
The investigators study the efficacy of a combination of dry needling plus manual therapy against sham dry needling plus manual therapy in the treatment of chronic neck pain. The investigators identify the most active trigger point in the upper trapezius and levator scapulae and administer two treatments, with an interval of 7 days, with a follow up 30 days after the first intervention. The primary outcome is the Visual Analogue Scale of Pain. Secondary outcomes ar pressure pain threshold, Neck Disability Index (NDI) questionnaire and range of motion.
Eligibility Criteria
Inclusion criteria
- Neck pain for at least three months (or more)
- An active trigger point in either the upper trapezius or the levator scapulae
Exclusion criteria
- Treatment for neck pain within the previous six months
- Neck Whiplash
- Fibromyalgia
- Infection in the area under treatment
- Pharmacological treatment with anti-coagulants
- Fear to needles
- Degenerative conditions
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT02435966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.